Pan-cancer analysis of CLDN18.2 shed new insights on the targeted therapy of upper gastrointestinal tract cancers

• Autori principali: Jun Wu (Autore), Jinghua Lu (Autore), Qiuyue Chen (Autore), Haojie Chen (Autore), Yongqiang Zheng (Autore), Minggang Cheng (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2024-11-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

BackgroundCLDN18.2 is a widely researched drug target. However, previous research has primarily been based on immunohistochemistry results and focused on gastric cancer.MethodsTo analyze the potential cancer-targeting effect of CLDN18.2 from a multi-omics perspective, this study quantified CLDN18.2...